The serum ApoB/ApoA-I concentrations on admission were significantly higher in patients with stroke recurrence at 1 year compared to those with good prognosis (median 1.01 mmol/L vs. 0.84 mmol/L, P < 0.001). The gene discussed is APOB; the disease is stroke disorder.